Neonatal withdrawal syndrome associated with hydroxyzine hydrochloride

Am J Dis Child. 1977 May;131(5):529-30. doi: 10.1001/archpedi.1977.02120180043007.

Abstract

To our knowledge, this is the first report of a neonatal withdrawal syndrome associated with maternal usage of 600 mg daily of hydroxyzine hydrochloride throughout pregnancy. This observation suggests that the use of high doses of this agent in pregnancy should be avoided.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Female
  • Fetal Blood / analysis
  • Humans
  • Hydroxyzine / adverse effects*
  • Hydroxyzine / blood
  • Infant, Newborn
  • Infant, Newborn, Diseases / chemically induced*
  • Pregnancy
  • Substance Withdrawal Syndrome / etiology*

Substances

  • Hydroxyzine